...
机译:肝法X受体蛋白水平和循环成纤维细胞生长因子19患儿患有NAFLD NAFLD的儿童浓度
Hepato‐metabolic UnitBambino Gesù Children's HospitalRome Italy;
Liver Research UnitBambino Gesù Children's HospitalRome Italy;
Hepato‐metabolic UnitBambino Gesù Children's HospitalRome Italy;
Hepato‐metabolic UnitBambino Gesù Children's HospitalRome Italy;
Hepato‐metabolic UnitBambino Gesù Children's HospitalRome Italy;
Histopathology UnitBambino Gesù HospitalRome Italy;
Liver Research UnitBambino Gesù Children's HospitalRome Italy;
Microscopy UnitBambino Gesù Children's HospitalRome Italy;
Division of General PediatricsDepartment of Pediatrics and Adolescent MedicineGraz Austria;
Division of General PediatricsDepartment of Pediatrics and Adolescent MedicineGraz Austria;
Faculty of MedicineUniversity of SouthamptonSouthampton UK;
Faculty of MedicineUniversity of SouthamptonSouthampton UK;
children; FGF 19; FXR; NAFLD; NASH;
机译:肝法X受体蛋白水平和循环成纤维细胞生长因子19患儿患有NAFLD NAFLD的儿童浓度
机译:成纤维细胞生长因子19治疗可减轻法呢素X受体(Fxr)-空小鼠肝脂质代谢的破坏。
机译:法呢素X受体和成纤维细胞生长因子15/19抑制载脂蛋白(a)的合成:迈向选择性脂蛋白(a)治疗剂的一步
机译:成纤维细胞生长因子-2与分离的完整细胞表面受体结合的计算模型:成纤维细胞生长因子-2浓度,流量和递送模式的影响
机译:成纤维细胞生长因子-19:一种抑制肝脂肪酸合成的新因子。
机译:肥胖相关NAFLD患者的基础代谢率脾脏体积与肝生长因子水平之间是否存在联系?
机译:肝法X受体蛋白水平和循环成纤维细胞生长因子19患儿在NAFLD中的浓度